We investigated the role of IL-33, IL-1R1, and MyD88 in the development of endometriosis in mice, and demonstrated the potential of inhibitors for IL-1/IL-33 and their signaling pathway as therapeutic targets for endometriosis. The gene discussed is IL33; the disease is endometriosis.